|

GLP-1 Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: GLP-1 Agonist, Glucagon-like peptide-1

Top Sponsors

  • University of Pennsylvania1
  • Rigshospitalet, Denmark1
  • Northwestern University1

Indications

  • Diabetes2
  • Pancreatic Insufficiency1
  • Healhty1
  • Cystic Fibrosis1
  • Weight Loss1

Other1 trial

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
N/A

Chicago, Illinois1 trial

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Northwestern Memorial Hospital

Philadelphia, Pennsylvania1 trial

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Children's Hospital of Philadelphia and University of Pennsylvania

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.